Literature DB >> 17008397

A purine analog kinase inhibitor, calcium/calmodulin-dependent protein kinase II inhibitor 59, reveals a role for calcium/calmodulin-dependent protein kinase II in insulin-stimulated glucose transport.

Nicky Konstantopoulos1, Seb Marcuccio, Stella Kyi, Violet Stoichevska, Laura A Castelli, Colin W Ward, S Lance Macaulay.   

Abstract

Olomoucine is known as a cyclin-dependent kinase inhibitor. We found that olomoucine blocked insulin's ability to stimulate glucose transport. It did so without affecting the activity of known insulin signaling proteins. To identify the olomoucine-sensitive kinase(s), we prepared analogs that could be immobilized to an affinity resin to isolate binding proteins. One of the generated analogs inhibited insulin-stimulated glucose uptake with increased sensitivity compared with olomoucine. The IC(50) for inhibition of insulin-stimulated glucose uptake occurred at analog concentrations as low as 0.1 microM. To identify proteins binding to the analog, [(35)S]-labeled cell lysates prepared from 3T3-L1 adipocytes were incubated with analog chemically cross-linked to a resin support and binding proteins analyzed by SDS-PAGE. The major binding species was a doublet at 50-60 kDa, which was identified as calcium/calmodulin-dependent protein kinase II (CaMKII) by N-terminal peptide analysis and confirmed by matrix-assisted laser desorption ionization-mass spectrometry as the delta- and beta-like isoforms. To investigate CaMKII involvement in insulin-stimulated glucose uptake, 3T3-L1 adipocytes were infected with retrovirus encoding green fluorescent protein (GFP)-hemagluttinin tag (HA)-tagged CaMKII wild-type or the ATP binding mutant, K42M. GFP-HA-CaMKII K42M cells had less kinase activity than cells expressing wild-type GFP-HA-CaMKII. Insulin-stimulated glucose transport was significantly decreased (approximately 80%) in GFP-HA-CaMKII K42M cells, compared with nontransfected cells, and cells expressing either GFP-HA-CaMKII or GFP-HA. There was not a concomitant decrease in insulin-stimulated GLUT4 translocation in GFP-HA-CaMKII K42M cells when compared with GFP-HA alone. However, insulin-stimulated GLUT4 translocation in GFP-HA-CaMKII cells was significantly higher, compared with either GFP-HA or GFP-HA-CaMKII K42M cells. Our results implicate the involvement of CaMKII in glucose transport in a permissive role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008397     DOI: 10.1210/en.2006-0446

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Nonspecific, reversible inhibition of voltage-gated calcium channels by CaMKII inhibitor CK59.

Authors:  Andrew S Karls; Michelle Mynlieff
Journal:  Cell Mol Neurobiol       Date:  2013-05-09       Impact factor: 5.046

2.  Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS.

Authors:  Kurt Højlund; Zhengping Yi; Hyonson Hwang; Benjamin Bowen; Natalie Lefort; Charles R Flynn; Paul Langlais; Susan T Weintraub; Lawrence J Mandarino
Journal:  Mol Cell Proteomics       Date:  2007-10-01       Impact factor: 5.911

3.  Dab1 stabilizes its interaction with Cin85 by suppressing Cin85 phosphorylation at serine 587.

Authors:  Bior K Bior; Bryan A Ballif
Journal:  FEBS Lett       Date:  2012-11-21       Impact factor: 4.124

4.  The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes.

Authors:  Vasiliki Lalioti; Gemma Muruais; Ana Dinarina; Josef van Damme; Joel Vandekerckhove; Ignacio V Sandoval
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

5.  Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII.

Authors:  Yan Wei; Chanshuai Han; Yujing Wang; Beibei Wu; Tao Su; Ying Liu; Rongqiao He
Journal:  Aging Cell       Date:  2015-06-11       Impact factor: 9.304

6.  Regulation of myosin light chain kinase during insulin-stimulated glucose uptake in 3T3-L1 adipocytes.

Authors:  Shelly Woody; Richard Stall; Joseph Ramos; Yashomati M Patel
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

7.  CAMKII as a therapeutic target for growth factor-induced retinal and choroidal neovascularization.

Authors:  Sadaf Ashraf; Samuel Bell; Caitriona O'Leary; Paul Canning; Ileana Micu; Jose A Fernandez; Michael O'Hare; Peter Barabas; Hannah McCauley; Derek P Brazil; Alan W Stitt; J Graham McGeown; Tim M Curtis
Journal:  JCI Insight       Date:  2019-03-21

8.  Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector Functions.

Authors:  Maxi Scheiter; Björn Bulitta; Marco van Ham; Frank Klawonn; Sebastian König; Lothar Jänsch
Journal:  Front Immunol       Date:  2013-03-18       Impact factor: 7.561

9.  3T3-L1 preadipocytes exhibit heightened monocyte-chemoattractant protein-1 response to acute fatty acid exposure.

Authors:  Aimee L Dordevic; Nicky Konstantopoulos; David Cameron-Smith
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.